Strong Christy L, Guerra Horacio P, Mathew Kiran R, Roy Nervik, Simpson Lacy R, Schiller Martin R
Nevada Institute of Personalized Medicine and School of Life Sciences, University of Nevada Las Vegas, Las Vegas, NV, United States of America.
PLoS One. 2015 May 6;10(5):e0125652. doi: 10.1371/journal.pone.0125652. eCollection 2015.
HIV-1 integrates its proviral DNA genome into the host genome, presenting barriers for virus eradication. Several new gene-editing technologies have emerged that could potentially be used to damage integrated proviral DNA. In this study, we use transcription activator-like effector nucleases (TALENs) to target a highly conserved sequence in the transactivation response element (TAR) of the HIV-1 proviral DNA. We demonstrated that TALENs cleave a DNA template with the HIV-1 proviral target site in vitro. A GFP reporter, under control of HIV-1 TAR, was efficiently inactivated by mutations introduced by transfection of TALEN plasmids. When infected cells containing the full-length integrated HIV-1 proviral DNA were transfected with TALENs, the TAR region accumulated indels. When one of these mutants was tested, the mutated HIV-1 proviral DNA was incapable of producing detectable Gag expression. TALEN variants engineered for degenerate recognition of select nucleotide positions also cleaved proviral DNA in vitro and the full-length integrated proviral DNA genome in living cells. These results suggest a possible design strategy for the therapeutic considerations of incomplete target sequence conservation and acquired resistance mutations. We have established a new strategy for damaging integrated HIV proviral DNA that may have future potential for HIV-1 proviral DNA eradication.
HIV-1将其前病毒DNA基因组整合到宿主基因组中,为病毒根除带来了障碍。已经出现了几种新的基因编辑技术,它们有可能被用于破坏整合的前病毒DNA。在本研究中,我们使用转录激活样效应核酸酶(TALENs)靶向HIV-1前病毒DNA反式激活应答元件(TAR)中的一个高度保守序列。我们证明TALENs在体外可切割带有HIV-1前病毒靶位点的DNA模板。在HIV-1 TAR控制下的绿色荧光蛋白(GFP)报告基因,通过转染TALEN质粒引入的突变而被有效失活。当用TALENs转染含有全长整合HIV-1前病毒DNA的感染细胞时,TAR区域积累了插入缺失。当测试其中一个突变体时,突变的HIV-1前病毒DNA无法产生可检测到的Gag表达。为简并识别特定核苷酸位置而设计的TALEN变体在体外也能切割前病毒DNA,并能切割活细胞中的全长整合前病毒DNA基因组。这些结果为针对不完全的靶序列保守性和获得性抗性突变的治疗考量提供了一种可能的设计策略。我们已经建立了一种破坏整合HIV前病毒DNA的新策略,这可能在未来根除HIV-1前病毒DNA方面具有潜力。